US EditionBiosensors Imperia Delivery System Receives CE Mark Approval - Cardiac Interventions Today
Summary by Cardiac Interventions Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Biosensors Imperia Delivery System Receives CE Mark Approval - Cardiac Interventions Today
July 17, 2025—Biosensors International recently announced it received CE Mark certification for the Imperia delivery system under the European Union Medical Device Regulation 2017/745. The Imperia device is now commercially available across Europe. According to the company, the Imperia device is part of the Biosensors Allegra self-expanding, supra-annular, transcatheter heart valve (THV). Allegra is intended for transfemoral implantation of the …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
